Case of Fusarium paronychia successfully treated with occlusive dressing of antifungal cream.

Abstract

We report a case of refractory Fusarium paronychia in a 42-year-old man with Behçet's disease receiving oral cyclosporin and corticosteroid. Symptoms resembling candidal paronychia of his little finger could not be cured by topical ketoconazole and oral terbinafine. The pathogen was identified as Fusarium solani species complex by gene analysis, and was multiple drug resistant. The case eventually resolved by occlusive dressing therapy with 0.5% amorolfine cream for 3 months.

• Authors: Isamu Ikeda, Tadashi Ohno, Hideaki Ohno, Yoshitsugu Miyazaki, Katsutaro Nishimoto, Satoshi Fukushima, Takamitsu Makino, Hiromobu Ihn
• Journal: The Journal of dermatology (J Dermatol) Vol. 41 Issue 4 Pg. 340-2 (Apr 2014) ISSN: 1346-8138 [Electronic] England
• PMID: 24533442 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2014 Japanese Dermatological Association.

Chemical References

• Antifungal Agents
• Immunosuppressive Agents
• Morpholines
• amorolfine

Topics

• Adult
• Antifungal Agents (administration & dosage)
• Behcet Syndrome (complications, drug therapy)
• Fusariosis (drug therapy, etiology, microbiology)
• Fusarium (drug effects, genetics, isolation & purification)
• Hand Dermatoses (drug therapy, etiology, microbiology)
• Humans
• Immunosuppressive Agents (adverse effects)
• Male
• Morpholines (administration & dosage)
• Occlusive Dressings
• Onychomycosis (drug therapy, etiology, microbiology)